Chromosomal translocations in human malignant hematopoiesis. Structural and functional consequences;Conséquences moléculaires et fonctionnelles des anomalies chromosomiques des hémopathies malignes humaines

Pathologie Biologie

Volumn 51, Issue 6, 2003, Pages 382-389

  Khac, F Nguyen ^a,b   Bernard, O A ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Chromosomal translocations; Leukemogenesis; Oncogenes

Indexed keywords

CHROMOSOME TRANSLOCATION; GENE DELETION; GENE IDENTIFICATION; GENE MAPPING; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMOGENESIS; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; PATHOPHYSIOLOGY; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0041859719     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(03)00113-5     Document Type: Article

References (48)

1. Gisselbrecht S. Oncogènes et leucémies: historique et perspectives. Médecine et Science 2003;19:201-10.
2. Rabbitts TH. Chromosomal translocations in human cancers. Nature 1994;371:143-9.
3. Bernard OA, Busson-LeConiat M, Ballerini P, Mauchauffe M, Della Valle V, Monni R, et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32)., is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2001;15:1495-504.
4. Ballerini P, Blaise A, Busson-Le Coniat M, Su XY, Zucman-Rossi J, Adam M, et al. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood 2002;100:991-7.
5. Begley CG, Green AR. The SCL gene: from case report to critical hematopoietic regulator. Blood 1999;93:2760-70.
6. Quon KC, Berns A. Haplo-insufficiency? Let me count the ways. Genes Dev 2001;15:2917-21.
7. Pluk H, Dorey K, Superti-Furga G. Autoinhibition of c-Abl. Cell 2002;108:247-59.
8. Ichikawa H, Shimizu K, Katsu R, Ohki M. Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS). Mol Cell Biol 1999;19:7639-50.
9. Speck NA, Gilliland DG. Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2002;2:502-13.
10. Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. Embo J 2001;20:6969-78.
11. Zhu J, Chen Z, Lallemand-Breitenbach V, de The H. How acute promyelocytic leukaemia revived arsenic. Nat Rev Cancer 2002;2:705-13.
12. Roumier C, Fenaux P, Lafage M, Imbert M, Eclache V, Preudhomme C. New mechanisms of AML1 gene alteration in hematological malignancies. Leukemia 2003;17:9-16.
13. Ito Y, Miyazono K. RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev 2003;13:43-7.
14. Downing JR. The core-binding factor leukemias: lessons learned from murine models. Curr Opin Genet Dev 2003;13:48-54.
15. Cai Z, de Bruijn M, Ma X, Dortland B, Luteijn T, Downing RJ, et al. Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo. Immunity 2000;13:423-31.
16. Gilliland DG, Tallman MS. Focus on acute leukemias. Cancer Cell 2002;1:417-20.
17. Kelly LM, Kutok JL, Williams IR, Boulton CL, Amaral SM, Curley DP, et al. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model. Proc Natl Acad Sci U S A 2002;99:8283-8.
18. Bassing CH, Swat W, Alt FW. The mechanism and regulation of chromosomal V(D)J recombination. Cell 2002;109:S45-55.
19. Finette BA, Poseno T, Albertini RJ. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children. Cancer Res 1996;56:1405-12.
20. Eguchi-Ishimae M, Eguchi M, Ishii E, Miyazaki S, Ueda K, Kamada N, et al. Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals. Blood 2001;97:737-43.
21. Wiemels JL, Alexander FE, Cazzaniga G, Biondi A, Mayer SP, Greaves M. Microclustering of TEL-AML1 translocation breakpoints in childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 2000;29:219-28.
22. Thandla SP, Ploski JE, Raza-Egilmez SZ, Chhalliyil PP, Block AW, de Jong PJ. ETV6-AML1 translocation breakpoints cluster near a purine/pyrimidine repeat region in the ETV6 gene. Blood 1999;93:293-9.
23. Mercher T, Busson-Le Coniat M, Khac FN, Ballerini P, Mauchauffe M, Bui H, et al. Recurrence of OTT-MAL fusion in t(1;22) of infant AML-M7. Genes Chromosomes Cancer 2002;33:22-8.
24. Zucman-Rossi J, Legoix P, Victor JM, Lopez B, Thomas G. Chromosome translocation based on illegitimate recombination in human tumors. Proc Natl Acad Sci U S A 1998;95:11786-91.
25. Stanulla M, Chhalliyil P, Wang J, Jani-Sait SN, Aplan PD. Mechanisms of MLL gene rearrangement: site-specific DNA cleavage within the breakpoint cluster region is independent of chromosomal context. Hum Mol Genet 2001;10:2481-91.
26. Dobson CL, Warren AJ, Pannell R, Forster A, Lavenir I, Corral J, et al. The m11-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. Embo J 1999;18:3564-74.
27. Felix CA. Leukemias related to treatment with DNA topoisomerase II inhibitors. Med Pediatr Oncol 2001;36:525-35.
28. Miyamoto T, Weissman IL, Akashi K. AML1/ETO - expressing non-leukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci U S A 2000;97:7521-6.
29. So C, Karsunky H, Passegué E, Cozzio A, Weissman I, Cleary M. MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. Cancer Cell 2003;3:161-71.
30. Greaves M. Childhood leukaemia. Bmj 2002;324:283-7.
31. Ford AM, Ridge SA, Cabrera ME, Mahmoud H, Steel CM, Chan LC, et al. utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 1993;363:358-60.
32. Janz S, Potter M, Rabkin CS. Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer 2003;36:211-23.
33. Ernst P, Wang J, Korsmeyer SJ. The role of MLL in hematopoiesis and leukemia. Curr Opin Hematol 2002;9:282-7.
34. Ayton PM, Cleary ML. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 2001;20:5695-707.
35. Salomon-Nguyen F, Della-Valle V, Mauchauffe M, Busson-Le Coniat M, Ghysdael J, Berger R. The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion. Proc Natl Acad Sci U S A 2000;97:6757-62.
36. Rubnitz JE, Pui CH, Downing JR. The role of TEL fusion genes in pediatric leukemias. Leukemia 1999;13:6-13.
37. Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor beta to a novel ets-like gene, tel., in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994;77:307-16.
38. Kim CA, Phillips ML, Kim W, Gingery M, Tran HH, Robinson MA, et al. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. Embo J 2001;20:4173-82.
39. Cools J, Mentens N, Odero MD, Peeters P, Wlodarska I, Delforge M, et al. Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13). Blood 2002;99:1776-84.
40. Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC, Komori T, et al. Differential Requirements for Runx Proteins in CD4 Repression and Epigenetic Silencing during T Lymphocyte Development. Cell 2002;111:621-33.
41. Mikkola HK, Klintman J, Yang H, Hock H, Schlaeger TM, Fujiwara Y, et al. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature 2003;421:547-51.
42. Hall MA, Curtis DJ, Metcalf D, Elefanty AG, Sourris K, Robb L, et al. The critical regulator of embryonic hematopoiesis, SCL., is vital in the adult for megakaryopoiesis., erythropoiesis., and lineage choice in CFU-S12. Proc Natl Acad Sci U S A 2003;100:992-7.
43. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-54.
44. Langenau DM, Traver D, Ferrando AA, Kutok JL, Aster JC, Kanki JP, et al. Myc-induced T cell leukemia in transgenic zebrafish. Science 2003;299:887-90.
45. Drexler HG. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 1998;12:845-59.
46. Trotta R, Vignudelli T, Candini O, Intine RV, Pecorari L, Guerzoni C, et al. BCR/ABL activates mdm2 mRNA translation via the La antigen. Cancer Cell 2003;3:145-60.
47. Britos-Bray M, Ramirez M, Cao W, Wang X, Liu PP, Civin CI. CBFbeta-SMMHC, expressed in M4eo acute myeloid leukemia, reduces p53 induction and slows apoptosis in hematopoietic cells exposed to DNA-damaging agents. Blood 1998;92:4344-52.
48. Linggi B, Muller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, et al. The t(8;21) fusion protein., AML1 ETO., specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Nat Med 2002;8:743-50.